SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-300140
Filing Date
2022-12-07
Accepted
2022-12-07 16:04:38
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 d425451d424b5.htm 424B5 455354
2 EX-FILING FEES d425451dexfilingfees.htm EX-FILING FEES 29070
3 GRAPHIC g386701g01k00.jpg GRAPHIC 40843
4 GRAPHIC g425451g1205230547790.jpg GRAPHIC 3526
5 GRAPHIC g425451g1205230548035.jpg GRAPHIC 35884
6 GRAPHIC g425451g1205230548157.jpg GRAPHIC 3944
  Complete submission text file 0001193125-22-300140.txt   598419
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254661 | Film No.: 221450263
SIC: 2834 Pharmaceutical Preparations